Biden Administration Approves Funding to Combat OUD in Rural Areas
Today, the Biden-Harris Administration announced that it is providing nearly $90 million to help rural communities combat opioid use disorders (OUD) and other forms of substance use disorders (SUD), and to improve access to maternal and obstetrics care. This funding is being distributed by the U.S. Department of Health and Human Services (HHS) through the […]
SUD Treatment and Recovery Loan Repayment Program
This week, the Health Resources and Services Administration (HRSA) announced a new Substance Use Disorder Treatment and Recovery Loan Repayment Program (STAR LRP), open now through July 22, 2021, at 7:30 pm ET. The program will repay educational loans for eligible staff up to $250,000 for six years of work. Join HRSA’s STAR LRP application […]
Biden-Harris Administration Calls for Historic Levels of Funding to Address Addiction and Overdose
The Biden-Harris Administration submitted to Congress the President’s Budget for fiscal year (FY) 2022. The Budget invests an unprecedented $41 billion in public safety and public health approaches to address addiction and the overdose epidemic, including significant increases for prevention and treatment of substance use disorders. Within the budget, more than 57% of all requested […]
An important announcement from the Department of Health and Human Services
We wanted to share this important announcement from Health and Human Services: In an effort to get evidenced-based treatment to more Americans with opioid use disorder, the Department of Health and Human Services (HHS) is releasing new buprenorphine practice guidelines that among other things, remove a longtime requirement tied to training, which some practitioners have […]
ICYMI: SAMHSA’s New Series of Advisories on Substance Use Disorder Treatment
SAMHSA has published a series of Advisories based on existing Treatment Improvement Protocols (TIPs) and Technical Assistance Publications (TAPs). These Advisories summarize updated guidance and recommendations on topics in the substance use disorder (SUD) treatment field. View Advisories
Announcing President Biden’s New Team and Priorities at ONDCP
Dear Friends, I’m writing to introduce myself and to provide some updates for you on the Biden-Harris Administration’s efforts to quickly bring on committed and experienced leadership at ONDCP. On the first day of the Administration, I was sworn in as Deputy Director for National Drug Control Policy. I will serve as Acting Director until […]
FAQs About 42 CFR Part 2
Following a webinar hosted by American Academy of Addiction Psychiatry, American Psychiatric Association, and American Society for Addiction Medicine regarding 42 CFR Part 2, the Center of Excellence for Protected Health Information (CoE-PHI) prepared the following answers to frequently asked questions (FAQs) that were raised by participants. View FAQs
HHS Proposes to Eliminate MAT Waiver Requirement for Some Physicians
Eliminates X-Waiver Requirement for DEA-Registered Physicians Today, the U.S. Department of Health and Human Services is announcing it will publish Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder*, to expand access to medication-assisted treatment (MAT) by exempting physicians from certain certification requirements needed to prescribe buprenorphine for opioid use disorder (OUD) […]
Pediatricians Issue Guidance on Opioid Use During Pregnancy
American Academy of Pediatrics Calls for Systemic, Coordinated and Holistic Approach to Help Mothers, Infants Affected by Opioid Crisis Read Article
DEA Issues Interim Final Rule Clarifying MAT Dispensing
Implementation of the Substance Use-Disorder Prevention that Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment Read the document
